Adma Biologics (ADMA) shares soared 10.2% in the last trading session to close at $20.61. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...

Scientists recently unveiled a first-of-its-kind authentication protocol for wireless, battery-free, ultraminiaturized implants that ensures these devices remain protected while still allowing ...

The traditional single-doctor model is giving way to multidisciplinary teams, where specialists collaborate to provide ...

Fan Zhang, Ph.D., sees artificial intelligence as a pathway to finding an effective way to combat an intractable enemy: ...

assistant professor of genitourinary medical oncology, were awarded $1 million by the Cancer Prevention and Research Institute of Texas (CPRIT) to develop artificial intelligence (AI) tools that ...

Editor’s note: The podcast Chasing Life With Dr. Sanjay Gupta explores the medical science behind some of life’s mysteries big and small. You can listen to episodes here. Laurel Bristow ...

Today’s health and medical science professionals need to be proficient in their chosen field, committed to helping others, and driven to take on the unique and ever-changing challenges facing modern ...

Scientists have captured the first detailed 'molecular movie' showing DNA being unzipped at the atomic level -- revealing how cells begin the crucial process of copying their genetic material.

The European Union on Wednesday outlined the steps that Apple must take to open up its iPhone and iPad operating systems to ...

The team is developing an AI model that can fact-check itself. To achieve this, they created a Causal Knowledge Graph (CKG) — a well-known format that organizes information from trusted medical ...

For years, manufacturing and engineering companies have been using digital models of products and systems for enhanced design ...

The company’s shares have lost 7.2% so far this year compared with the medical instrument industry ... as well as the breach of the 200-DMA, which implies further weakness for the stock.